Genemilo, Renmark G.

HRN: 24-49-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2024
CEFTRIAXONE 1G (VIAL)
01/20/2024
01/27/2024
IV DRIP
750mg
Q12
Sepsis
Waiting Final Action 
01/24/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/24/2024
01/30/2024
IV
1.2g
Q8
Sepsis
Waiting Final Action 
01/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/24/2024
01/30/2024
IV
170mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: